首页> 外文OA文献 >Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma

【2h】

Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma

机译：用新的苯并咪唑衍生物治疗携带吡咯烷侧链克服肝细胞癌的索拉非尼抗性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fat-Moon Suk; Chao-Lien Liu; Ming-Hua Hsu; Yu-Ting Chuang; Jack P. Wang; Yi-Jen Liao;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma [J] . Fat-Moon Suk, Chao-Lien Liu, Ming-Hua Hsu, Scientific reports. . 2019,第1期

机译：用新的苯并咪唑衍生物治疗携带吡咯烷侧链克服肝细胞癌的索拉非尼抗性
2. Commentary Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms [J] . Jiang Chen, Dan G. Duda EBioMedicine . 2020,第6期

机译：评注克服嗜胞嘧啶治疗抗性肝癌：在快速改变治疗范式时的未来视角
3. Treatment with low-dose sorafenib in combination with a novel benzimidazole derivative bearing a pyrolidine side chain provides synergistic anti-proliferative effects against human liver cancer [J] . Ming-Hua Hsu, Shih-Ming Hsu, Yu-Cheng Kuo, RSC Advances . 2017,第26期

机译：小剂量索拉非尼与带有吡咯烷侧链的新型苯并咪唑衍生物联合治疗可提供抗人肝癌的协同抗增殖作用
4. In-depth Proteomic Analysis of Sorafenib-induced Resistance in Hepatocellular Carcinoma Using High Resolution LC-MS/MS [C] . Junho Park, Dohyun Han, Su Jong Yu, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：高分辨率LC-MS / MS的肝细胞癌中索拉非尼诱导抗性的深入蛋白质组学分析
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms [O] . Jiang Chen, Dan G. Duda 2020

机译：克服索拉非尼在肝细胞癌中的耐药性：在治疗模式迅速变化的时代的未来前景
7. Treatment with low-dose sorafenib in combination with a novel benzimidazole derivative bearing a pyrolidine side chain provides synergistic anti-proliferative effects against human liver cancer [O] . Ming-Hua Hsu, Shih-Ming Hsu, Yu-Cheng Kuo, 2017

机译：用低剂量索拉昔韦与携带吡咯烷侧链的新型苯并咪唑衍生物的处理为人类肝癌提供协同抗增殖作用

Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅